BacAlt Biosciences raises Rs 18 crore in round led by Avaana Capital; startup valued at $8 million
Biotech startup BacAlt Biosciences has raised Rs 18 crore in a funding round led by early-stage investment firm Avaana Capital. The company is currently valued at $8 million.
The round also saw participation from Lubrizol InnoVentures, the innovation arm of global speciality chemicals provider Lubrizol.
The startup will use the funds to scale R&D processes, build pilot production facilities, expand its team, and develop go-to-market strategies for geographic expansion.
